ST316, a β-catenin/BCL9 antagonist, demonstrated safety, target engagement, and early antitumor activity in advanced solid tumors.

Rodabe N. Amaria, MD, explains a trial of OBX-115, a novel engineered tumor infiltrating lymphocyte therapy, in checkpoint ...

About PD-1 Inhibitors PD-1 inhibitors work by blocking the PD-1 (programmed death-1) receptor on T cells, preventing cancer cells from evading the immune system and restoring the body’s ability to ...

Perspective, Therapeutics (CATX) announced that the first patient was dosed in a new cohort of a Phase 1/2a trial evaluating the safety of ...

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...

Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...

The trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, March 18, 2025, the moon is 18 days old and is in the Waning Gibbous phase of its lunar ...

Marvel Phase 5's time grows short. The midsection of the comic book giant's Multiverse Saga is down to its last two projects, so there's no time like the present to learn more about that pair.